PFD report

Hannah Enola Ayamo Jacobs · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 20 Aug 2024•East London

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
5

Raised in this report

Recipients
6

Named on the report

Responses found
6

Of 6 recipients

Stated actions
18

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised5

  1. Allergy plans failing to distinguish lip swelling as a potential anaphylaxis symptom
    Part of recurring concern: Failure to recognise and respond to anaphylaxis
  2. Insufficient education of parents and patients on safe AAI use when in doubt
    Part of recurring concern: Inadequate anaphylaxis safety education for patients, parents and schools
  3. Failure to recognise inability to swallow as a sign of anaphylaxis in dental settings
    Part of recurring concern: Failure to recognise and respond to anaphylaxis
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.11

  1. Action

    Develop an online allergy education platform covering anaphylaxis recognition, symptoms and management for healthcare and non-healthcare professionals.

    Stated by The British Society For Allergy & Clinical ImmunologyStated in progressThe respondent said that this action was in progress when they made their response on 30 August 2024.
  2. Action

    Develop anaphylaxis guidelines and patient information leaflets with patient organisations, including an accessible leaflet explaining anaphylaxis signs and symptoms.

    Stated by The British Society For Allergy & Clinical ImmunologyStated completedThe respondent said that this action was complete when they made their response on 30 August 2024.
  3. Action

    Develop and maintain allergy action plans distinguishing mild or moderate reactions from anaphylaxis and advising adrenaline if in doubt.

    Stated by The British Society For Allergy & Clinical ImmunologyStated completedThe respondent said that this action was complete when they made their response on 30 August 2024.

Respondent positions A position is what a recipient says about a concern when it does not describe a specific action.7

  1. Position

    The availability of adrenaline auto-injectors in pharmacies for emergencies cannot be commented on.

    Stated by The British Society For Allergy & Clinical ImmunologyUnable to actThe respondent said that a constraint prevented them from taking the relevant action.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Allergy plans failing to distinguish lip swelling as a potential anaphylaxis symptom

Wider context from the report

“• The other symptom Hannah demonstrated was swelling of her lips which is listed on allergy plans as a mild to moderate symptom and thus provided a false sense of reassurance to her mother that cetirizine was what she needed. ”

Is this part of a recurring concern?

Yes — Failure to recognise and respond to anaphylaxis.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Insufficient education of parents and patients on safe AAI use when in doubt

Wider context from the report

“• The risk of future deaths in the context of anaphylaxis remains in the absence of further consideration of what constitutes an anaphylactic reaction as opposed to a mild reaction, and the education of parents and patients of the safety of using AAIs (adrenaline auto injectors) IF IN DOUBT. ”

Is this part of a recurring concern?

Yes — Inadequate anaphylaxis safety education for patients, parents and schools.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to recognise inability to swallow as a sign of anaphylaxis in dental settings

Wider context from the report

“• The evidence at the inquest referred to allergy action plans discussed in the healthcare settings and given to parents and patients. Hannah displayed what appeared to be excessive salivation at the dentist which her paediatric consultant (who gave evidence) said, with the benefit of hindsight was actually a manifestation of her inability to swallow. This is a sign of anaphylaxis This was not recognised by dental staff as an inability to swallow and thus of anaphylaxis. ”

Is this part of a recurring concern?

Yes — Failure to recognise and respond to anaphylaxis.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of sufficiently clear distinction between anaphylactic and mild reactions

Wider context from the report

“• The risk of future deaths in the context of anaphylaxis remains in the absence of further consideration of what constitutes an anaphylactic reaction as opposed to a mild reaction, and the education of parents and patients of the safety of using AAIs (adrenaline auto injectors) IF IN DOUBT. ”

Is this part of a recurring concern?

Yes — Failure to recognise and respond to anaphylaxis.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Unavailability of AAI stock in chemists for emergencies

Wider context from the report

“• I was made aware there had been a shortage of AAI at the time but a vial of adrenaline was available at the chemist. However, it takes time to draw up. I am not sure if (assuming no national shortage) all chemists have AAI in stock for emergencies. ”

Is this part of a recurring concern?

Yes — Failure to ensure essential clinical equipment and supplies are available and serviceable.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Develop an online allergy education platform covering anaphylaxis recognition, symptoms and management for healthcare and non-healthcare professionals.

Verbatim wording from the response

“The BSACI Allergy Action Plans do state that difficulty swallowing is a manifestation of anaphylaxis. These plans were developed with allergy healthcare professionals and patient representatives. The BSACI is developing an online allergy education platform for all healthcare professionals and non-healthcare professionals which will include anaphylaxis. This will include the signs and symptoms and management approach for mild, moderate and severe allergic reactions. This will be rolled out extensively to a wide range of stakeholders. We would welcome the involvement of healthcare professionals across tertiary, secondary and primary care (e.g. Royal College of General Practitioners, Royal College of Nursing) in this activity, and healthcare leadership (e.g. NHS England, devolved nations heath boards, Integrated Care Boards).”

Source location

Response from BSACI
Page 1 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Develop anaphylaxis guidelines and patient information leaflets with patient organisations, including an accessible leaflet explaining anaphylaxis signs and symptoms.

Verbatim wording from the response

“BSACI has collaborated with patient organisations to develop guidelines and information leaflets. This includes an Anaphylaxis patient information leaflet which can be viewed here. This clearly states the signs and symptoms of anaphylaxis and is accessible to all patients.”

Source location

Response from BSACI
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Develop and maintain allergy action plans distinguishing mild or moderate reactions from anaphylaxis and advising adrenaline if in doubt.

Verbatim wording from the response

“The BSACI Allergy Action Plans have two boxes that clearly list the symptoms and signs of firstly a mild or moderate reaction and secondly anaphylaxis. These were developed with a wide range of healthcare professionals and patient groups. Additionally, plans state “if in doubt, give adrenaline”.”

Source location

Response from BSACI
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Roll out the online allergy education platform extensively to healthcare professionals, non-healthcare professionals and other relevant stakeholders.

Verbatim wording from the response

“The BSACI Allergy Action Plans do state that difficulty swallowing is a manifestation of anaphylaxis. These plans were developed with allergy healthcare professionals and patient representatives. The BSACI is developing an online allergy education platform for all healthcare professionals and non-healthcare professionals which will include anaphylaxis. This will include the signs and symptoms and management approach for mild, moderate and severe allergic reactions. This will be rolled out extensively to a wide range of stakeholders. We would welcome the involvement of healthcare professionals across tertiary, secondary and primary care (e.g. Royal College of General Practitioners, Royal College of Nursing) in this activity, and healthcare leadership (e.g. NHS England, devolved nations heath boards, Integrated Care Boards).”

Source location

Response from BSACI
Page 1 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Work with professional bodies to agree and support allergy standards of care and education.

Verbatim wording from the response

“The RCP will work with Royal College of Paediatrics and Child Health, Royal College of Pathologists, British Society for Immunology – Clinical Immunology Professional Network, British Society for Allergy and Clinical Immunology, dental and pharmacy professional groups, to agree and support standards of care and education related to allergy. This will include updating standards for allergy accreditation, including the adoption of the BSACI adult allergy action plan where many of the aspects related to this case are addressed including carrying adrenaline autoinjectors, and difficulty in swallowing is an indication for the use of adrenaline.”

Source location

Response from Royal College of Physicians
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Update allergy accreditation standards, including adoption of the BSACI adult allergy action plan.

Verbatim wording from the response

“The RCP will work with Royal College of Paediatrics and Child Health, Royal College of Pathologists, British Society for Immunology – Clinical Immunology Professional Network, British Society for Allergy and Clinical Immunology, dental and pharmacy professional groups, to agree and support standards of care and education related to allergy. This will include updating standards for allergy accreditation, including the adoption of the BSACI adult allergy action plan where many of the aspects related to this case are addressed including carrying adrenaline autoinjectors, and difficulty in swallowing is an indication for the use of adrenaline.”

Source location

Response from Royal College of Physicians
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Review CPD requirements and consider proposing changes to medical-emergency recommendations.

Verbatim wording from the response

“We are currently in the process of reviewing our CPD requirements, and we will consider whether we should propose changes to the recommendations regarding medical emergencies as part of the review. The review is expected to conclude in 2025, but some potential changes would require legislative changes, the timing of which is not under our control.”

Source location

Response from General Dental Council
Page 3 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Write to NICE requesting review of anaphylaxis symptoms and related guidance for dental professionals.

Verbatim wording from the response

“Whilst I note your concern that dental professionals did not recognise the early symptoms of anaphylaxis, I also note that the symptom of excessive salivation is not listed as a potential symptom in the NICE guidance. We will write to NICE to highlight this, and to ask them to consider reviewing the listed symptoms of anaphylaxis and their guidance to dental professionals more broadly.”

Source location

Response from General Dental Council
Page 3 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Provide national colleagues with updates on the regional review of adrenaline auto-injector use and supply.

Verbatim wording from the response

“The Pharmacy and Medicines Optimisation Team have been reviewing the use of AAIs and their supply. The detail of this work is still being finalised but my regional colleagues in London have been asked to ensure the national team are provided with updates on this work.”

Source location

Response from NHS England
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Review the use and supply of adrenaline auto-injectors.

Verbatim wording from the response

“The Pharmacy and Medicines Optimisation Team have been reviewing the use of AAIs and their supply. The detail of this work is still being finalised but my regional colleagues in London have been asked to ensure the national team are provided with updates on this work.”

Source location

Response from NHS England
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Continue widely promoting Paediatric Allergy Training study days across the child health workforce.

Verbatim wording from the response

“As the Royal College of Paediatrics and Child Health, we are primarily responsible for the education and training of paediatricians across the UK. We are not involved in the training of dentists and dental staff and have no role in the supply of epi-pens to pharmacies. As part of our training, we run CPD courses on child health topics that are of interest and relevance to the wider child health workforce. This includes Paediatric Allergy Training study days that focus on the practical clinical management of allergy in children and young people. These courses are suitable for all professionals seeing children with allergic disease. You can read more about these courses on our RCPCH Learning platform. We will ensure these continue to be widely promoted across the child health workforce.”

Source location

2024-0464 Response from Royal College of Paediatrics
Page 1 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The availability of adrenaline auto-injectors in pharmacies for emergencies cannot be commented on.

Verbatim wording from the response

“Concern 4 “I was made aware there had been a shortage of AAI at the time, but a vial of adrenaline was available at the chemist. However, it takes time to draw up. I am not sure if (assuming no national shortage) all chemists have AAI in stock for emergencies.””

Source location

Response from BSACI
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Potential CPD changes requiring legislation may be delayed because the timing of legislative changes is outside the respondent’s control.

Verbatim wording from the response

“We are currently in the process of reviewing our CPD requirements, and we will consider whether we should propose changes to the recommendations regarding medical emergencies as part of the review. The review is expected to conclude in 2025, but some potential changes would require legislative changes, the timing of which is not under our control.”

Source location

Response from General Dental Council
Page 3 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The current standards and guidance provide clear obligations, so additional or different standards are not currently considered necessary.

Verbatim wording from the response

“The current framework of standards and guidance sets out clear obligations for dental professionals to have appropriate training and keep medication on their premises to use in the event of a medical emergency. I think that it is appropriate to continue to require adherence to the RCG as set out at Standard 1.5 and other appropriate guidance, including the NICE guidance as set out in Standard 7.1.”

Source location

Response from General Dental Council
Page 3 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Excess salivation is not listed as anaphylaxis in national guidance, so dental staff reasonably did not interpret it as early anaphylaxis.

Verbatim wording from the response

“1. The evidence at the inquest referred to allergy action plans discussed in the healthcare settings and given to parents and patients. Hannah displayed what appeared to be excessive salivation at the dentist which her paediatric consultant (who gave evidence) said, with the benefit of hindsight was a manifestation of her inability to swallow. This is a sign of anaphylaxis. This was not recognised by dental staff as an inability to swallow and thus of anaphylaxis.”

Source location

Response from NHS England
Page 1 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Manufacturing medicines and addressing wider adrenaline autoinjector supply and shortage issues fall outside the regulatory role.

Verbatim wording from the response

“We are aware of ongoing and intermittent supply issues with adrenaline autoinjectors (AAIs) which have been lasting for several years. While we do not have a direct role in the manufacturing of medicines or wider issues such as supply and shortages, we understand that medicines shortages can cause problems for patients, carers and those supporting people living with life-threatening allergies requiring adrenaline.”

Source location

Response from General Pharmaceutical Council
Page 1 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The Department of Health and Social Care, manufacturers and wholesalers are best placed to answer specific medicine availability enquiries.

Verbatim wording from the response

“Specific enquiries about the availability of particular medicines, can be directed to the medicines supply team at the Department of Health and Social Care (DHSC) on ████████. Alongside manufacturers and wholesalers, they would be best placed to help answer any questions you may have regarding the availability of medicines.”

Source location

Response from General Pharmaceutical Council
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Training dentists and dental staff, and supplying adrenaline auto-injectors to pharmacies, fall outside the organisation’s role.

Verbatim wording from the response

“As the Royal College of Paediatrics and Child Health, we are primarily responsible for the education and training of paediatricians across the UK. We are not involved in the training of dentists and dental staff and have no role in the supply of epi-pens to pharmacies. As part of our training, we run CPD courses on child health topics that are of interest and relevance to the wider child health workforce. This includes Paediatric Allergy Training study days that focus on the practical clinical management of allergy in children and young people. These courses are suitable for all professionals seeing children with allergic disease. You can read more about these courses on our RCPCH Learning platform. We will ensure these continue to be widely promoted across the child health workforce.”

Source location

2024-0464 Response from Royal College of Paediatrics
Page 1 · response
Published 30 August 2024

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.7

  1. 1

    Continue promoting multidisciplinary allergy care, including dietetic support.

    Stated by Royal College of PhysiciansStated in progressThe respondent said that this action was in progress when they made their response on 30 August 2024.
  2. 2

    Continue highlighting self-management, allergen avoidance and access to service-user support groups through IQAS and more widely.

    Stated by Royal College of PhysiciansStated in progressThe respondent said that this action was in progress when they made their response on 30 August 2024.
  3. 3

    Develop the UK National Allergy Strategy through the expert advisory group on allergy.

    Stated by Royal College of PhysiciansStated in progressThe respondent said that this action was in progress when they made their response on 30 August 2024.
  4. 4

    Discuss Prevention of Future Deaths reports through the Regulation 28 Working Group and share their patient-safety learning across national and regional NHS services.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 30 August 2024.
  5. 5

    Review the communications approach for alerting GP practices about anaphylaxis auto-injector shortages.

    Stated by NHS EnglandStated in progressThe respondent said that this action was in progress when they made their response on 30 August 2024.
  6. 6

    Share information and local improvement suggestions from the report with paediatric members through the patient safety portal.

    Stated by Royal College of Paediatrics and Child HealthStated plannedThe respondent said that this action was planned when they made their response on 30 August 2024.
  7. 7

    Share anonymised report information with the Clinical Quality in Practice Committee for discussion.

    Stated by Royal College of Paediatrics and Child HealthStated plannedThe respondent said that this action was planned when they made their response on 30 August 2024.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Continue promoting multidisciplinary allergy care, including dietetic support.

Verbatim wording from the response

“We will also continue to promote multidisciplinary care for people with allergy including dietetic support. As a member of the expert advisory group on allergy (EAGA) the RCP is working on the development of the UK National Allergy Strategy. The UK National Allergy Strategy aims to provide a collaborative approach to improving health outcomes and other unmet needs of the allergic community across the UK.”

Source location

Response from Royal College of Physicians
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Continue highlighting self-management, allergen avoidance and access to service-user support groups through IQAS and more widely.

Verbatim wording from the response

“The RCP will continue to highlight the importance of education (around self-management and allergen avoidance) and access to service user support groups for services registered and accredited with IQAS, and more widely.”

Source location

Response from Royal College of Physicians
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Develop the UK National Allergy Strategy through the expert advisory group on allergy.

Verbatim wording from the response

“We will also continue to promote multidisciplinary care for people with allergy including dietetic support. As a member of the expert advisory group on allergy (EAGA) the RCP is working on the development of the UK National Allergy Strategy. The UK National Allergy Strategy aims to provide a collaborative approach to improving health outcomes and other unmet needs of the allergic community across the UK.”

Source location

Response from Royal College of Physicians
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Discuss Prevention of Future Deaths reports through the Regulation 28 Working Group and share their patient-safety learning across national and regional NHS services.

Verbatim wording from the response

“I would also like to provide further assurances on national NHS England work taking place around the Reports to Prevent Future Deaths. All reports received are discussed by the Regulation 28 Working Group, comprising Regional Medical Directors, and other clinical and quality colleagues from across the regions. This ensures that key learnings and insights around events, such as the sad death off Hannah, are shared across the NHS at both a national and regional level and helps us to pay close attention to any emerging trends that may require further review and action.”

Source location

Response from NHS England
Page 3 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Review the communications approach for alerting GP practices about anaphylaxis auto-injector shortages.

Verbatim wording from the response

“My Patient Safety colleagues in North East London have confirmed that community pharmacies were notified of the shortage of Jext, however they have not been able to confirm if the same message was sent to all GPs. They are therefore currently reviewing their communications approach to alerting GP practices. The Pharmacy and Medicines Optimisation Team do include updates from the MHRA in their newsletters along with a link to Medicines Supply Tool – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice and this provides information on national shortages and how to manage them.”

Source location

Response from NHS England
Page 2 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Share information and local improvement suggestions from the report with paediatric members through the patient safety portal.

Verbatim wording from the response

“The College will be sharing information and suggestions for local improvement from your report with our paediatric members via its patient safety portal. The anonymised information within your report will also be shared for discussion with the RCPCH Clinical Quality in Practice Committee, where further actions may be identified.”

Source location

2024-0464 Response from Royal College of Paediatrics
Page 1 · response
Published 30 August 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Share anonymised report information with the Clinical Quality in Practice Committee for discussion.

Verbatim wording from the response

“The College will be sharing information and suggestions for local improvement from your report with our paediatric members via its patient safety portal. The anonymised information within your report will also be shared for discussion with the RCPCH Clinical Quality in Practice Committee, where further actions may be identified.”

Source location

2024-0464 Response from Royal College of Paediatrics
Page 1 · response
Published 30 August 2024

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
6/6

Data last updated 7 September 2026